000			04298nam a22005657a 4500
001			sulb-eb0022065
003			BD-SySUS
005			20160413122221.0
007			cr nn 008mamaa
008			121009s2013 xxu| s |||| 0|eng d
020			_a9781461446699 _9978-1-4614-4669-9
024	7		_a10.1007/978-1-4614-4669-9 _2doi
050		4	_aRC321-580
072		7	_aPSAN _2bicssc
072		7	_aMED057000 _2bisacsh
082	0	4	_a612.8 _223
245	1	0	_aendoCANNABINOIDS _h[electronic resource] : _bActions at Non-CB1/CB2 Cannabinoid Receptors / _cedited by Mary E. Abood, Roger G Sorensen, Nephi Stella.
264		1	_aNew York, NY : _bSpringer New York : _bImprint: Springer, _c2013.
300			_aXII, 288 p. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aThe Receptors ; _v24
505	0		_aOverview of Non-Cannabinoid Receptors.Overview of Non-Classical Cannabinoid Receptors.Overview of Non-Cannabinoid Receptors: Chemistry and Modeling -- G-Protein Coupled Receptors.GPR55 in the CNS.The Role of GPR55 in Bone Biology.The Role of GPR55 in Cancer.GPR18 and NAGly signaling: New members of the endocannabinoid family or distant cousins?.Cannabinoid Signaling Through Non CB1/Non CB2 GPCR Targets in Microglia -- Ion Channels.Temperature-Sensitive Transient Receptor Potential Channels as Ionotropic Cannabinoid Receptors.Nonpsychoactive Cannabinoid Action on 5-HT3 and Glycine Receptors -- Transcription Factors.Peroxisome proliferator-activated receptors and inflammation.Peroxisome proliferator-activated nuclear receptors (PPAR) and drug addiction -- Conclusions/Therapeutic Potential.Conclusions: Therapeutic Potential of Novel Cannabinoid Receptors.
520			_aThe cloning of two G protein-coupled cannabinoid receptors, termed CB1 and CB2, in the early 1990s has stimulated and facilitated research conducted on the physiological function of cannabinoid actions in the brain and throughout the body. In the twenty years since the identification of these two receptors, endogenous ligands (endocannabinoids) for these receptors have been identified, their biosynthetic and metabolic pathways have been discerned, and their functional and regulatory action for signalling through CB1 and CB2 receptors have been described. More recently, it has become has become evident that cannabinoids exert actions at non-CB1, non-CB2 receptors. Much less is understood about these actions. Many of these novel “targets” are in the process of being characterized functionally and physiologically, and the therapeutic value of targeting these non-CB1, non-CB2 receptors is being evaluated. The purpose of this volume is to present the current knowledge on the atypical actions of cannabinoids on these new targets.   This book is intended as a scientific resource for cannabinoid researchers carrying out animal and human experiments, and for those who are interested in learning about future directions in cannabinoid research. Additionally, this book may be of value to investigators currently working outside the field of cannabinoid research who have an interest in learning about these compounds and their atypical cannabinoid signalling. This book provides insight into the potential medical application of cannabinoids and their therapeutic development for the treatment of human disease.
650		0	_aMedicine.
650		0	_aHuman physiology.
650		0	_aNeurosciences.
650		0	_aPharmacology.
650		0	_aProteins.
650		0	_aAnimal physiology.
650	1	4	_aBiomedicine.
650	2	4	_aNeurosciences.
650	2	4	_aHuman Physiology.
650	2	4	_aReceptors.
650	2	4	_aAnimal Physiology.
650	2	4	_aPharmacology/Toxicology.
700	1		_aAbood, Mary E. _eeditor.
700	1		_aSorensen, Roger G. _eeditor.
700	1		_aStella, Nephi. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9781461446682
830		0	_aThe Receptors ; _v24
856	4	0	_uhttp://dx.doi.org/10.1007/978-1-4614-4669-9
912			_aZDB-2-SBL
942			_2Dewey Decimal Classification _ceBooks
999			_c44157 _d44157